Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group.
作者信息
Vieillard-Baron Antoine, Flicoteaux Rémi, Salmona Maud, Chariot Appoline, De Maupeou D'Ableiges Bertrand, Darmon Michael, Batteux Frédéric
机构信息
Assistance Publique des Hôpitaux de Paris Boulogne, France.
Université de Paris Saclay Villejuif, France.
出版信息
Am J Respir Crit Care Med. 2022 Aug 1;206(3):349-363. doi: 10.1164/rccm.202202-0411LE.
Abstract
摘要
相似文献
1
Omicron Variant in the Critical Care Units of the Paris Metropolitan Area: The Reality Research Group.
Am J Respir Crit Care Med. 2022 Aug 1;206(3):349-363. doi: 10.1164/rccm.202202-0411LE.
2
[Intensive care: hypertechnology, mothering, personal implications].
Rev Infirm. 1985 Apr;35(7):28-9.
3
Increase in out-of-hospital cardiac arrest attended by the medical mobile intensive care units, but not myocardial infarction, during the 2003 heat wave in Paris, France.
Crit Care Med. 2009 Dec;37(12):3079-84. doi: 10.1097/CCM.0b013e3181b0868f.
4
Person-centred care in intensive care: a myth or reality?
Nurs Crit Care. 2012 Sep-Oct;17(5):225-6. doi: 10.1111/j.1478-5153.2012.00529.x.
5
Critical care nursing in Paris.
Focus Crit Care. 1986 Oct;13(5):11-5.
6
[Descriptive study of the patients admitted to an intensive care unit during the heat wave of August 2003 in France].
Presse Med. 2003 Nov 8;32(36):1690-8.
7
Delirium in intensive care: an under-diagnosed reality.
Rev Bras Ter Intensiva. 2013 Apr-Jun;25(2):137-47. doi: 10.5935/0103-507X.20130025.
8
COVID-19 epidemic in the Seine-Saint-Denis Department of Greater Paris: one month and three waves for a tsunami.
Eur J Emerg Med. 2020 Aug;27(4):274-278. doi: 10.1097/MEJ.0000000000000723.
9
[Critical care work: schedules and shifts].
Rev Infirm. 1985 Apr;35(7):22-3.
10
Deliberate drug poisonings admitted to an emergency department in Paris area - a descriptive study and assessment of risk factors for intensive care admission.
Eur Rev Med Pharmacol Sci. 2016;20(6):1174-9.
引用本文的文献
1
Clinical characteristics and prediction model of re-positive nucleic acid tests among Omicron infections by machine learning: a real-world study of 35,488 cases.
BMC Infect Dis. 2024 Dec 18;24(1):1406. doi: 10.1186/s12879-024-10297-0.
2
Assessing the impact of Delta and Omicron in German intensive care units: a retrospective, nationwide multistate analysis.
BMC Health Serv Res. 2024 Sep 23;24(1):1107. doi: 10.1186/s12913-024-11493-z.
3
Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China.
BMC Infect Dis. 2024 Aug 9;24(1):809. doi: 10.1186/s12879-024-09652-y.
4
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024.
Ann Intensive Care. 2024 Jun 28;14(1):101. doi: 10.1186/s13613-024-01319-w.
5
Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.
BMC Infect Dis. 2024 Feb 20;24(1):223. doi: 10.1186/s12879-024-09131-4.
6
Clinical outcomes during and beyond different COVID-19 critical illness variant periods compared with other lower respiratory tract infections.
Crit Care. 2023 Nov 6;27(1):427. doi: 10.1186/s13054-023-04722-0.
7
Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75, and BQ.1 compared to BA.5 in England.
Epidemiol Infect. 2023 Oct 31;151:e189. doi: 10.1017/S0950268823001760.
8
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive Care Med Exp. 2023 Aug 7;11(1):48. doi: 10.1186/s40635-023-00536-0.
9
Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
J Multidiscip Healthc. 2023 Jul 27;16:2117-2136. doi: 10.2147/JMDH.S419859. eCollection 2023.
10
Characterizing distinct profiles of immune and inflammatory response with age to Omicron infection.
Front Immunol. 2023 Jun 30;14:1189482. doi: 10.3389/fimmu.2023.1189482. eCollection 2023.
本文引用的文献
1
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.
EClinicalMedicine. 2022 Jun;48:101455. doi: 10.1016/j.eclinm.2022.101455. Epub 2022 May 20.
2
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
JAMA. 2022 Feb 8;327(6):546-558. doi: 10.1001/jama.2022.0028.
3
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Lancet. 2022 Jan 29;399(10323):437-446. doi: 10.1016/S0140-6736(22)00017-4. Epub 2022 Jan 19.
4
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
5
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.
JAMA. 2022 Feb 8;327(6):583-584. doi: 10.1001/jama.2021.24868.
6
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial.
JAMA. 2021 Dec 7;326(21):2161-2171. doi: 10.1001/jama.2021.20714.
7
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
Lancet. 2021 Dec 11;398(10317):2126-2128. doi: 10.1016/S0140-6736(21)02758-6. Epub 2021 Dec 3.
8
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA. 2021 Nov 23;326(20):2043-2054. doi: 10.1001/jama.2021.19499.
9
Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset.
Intensive Care Med. 2020 Sep;46(9):1714-1722. doi: 10.1007/s00134-020-06202-3. Epub 2020 Aug 11.
10
High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19.
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1039-1042. doi: 10.1164/rccm.202005-2007LE.
Zotero 插件